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the cases. Immunoluminometric and immunonepholomet-
ric methods were used for PCT (Procalcitonin) and CRP (C
reactive protein) detections, respectively.
Eighteen (39.13%) among the 46 primary JIA and EC
groups had infections in different regions of their body
whereas only two indivudials from the HC showed infec-
tions (p < 0.05). M. pneumoniae infections were found much
higher in the groups with primary and EC when compared
with the HC. Furthermore, C. jejuni IgG seropositivity was
detected signiﬁcantly higher in JIA group than that of
the HC. While, in JIA cases with regard to bacterial and
viral factors, PCT levels were not found signiﬁcantly higher
(0.02 ng/ml), the mean value for CRP levels in patients with
JIA were found 7.62mg/l. A statistically signiﬁcant differ-
ence was detected between the primary JIA and EC groups
and HC group for both PCT and CRP levels (p < 0.05).
In conclusion, the results of our study which is the ﬁrst
in this ﬁeld and including such a large group organisms in
the same serial for JIA pathogenesis gave the idea that
some microorganisms could trigger or worsen the clinical
appearence in subject level. In particular, M. pneumoniae ve
C. jejuni draw attention especially in primary JIA and EC. We
suppose that it is possible to prevent antigenic stimulation
and as a result to obtain recovery in clinical presentation
with early detection of microorganisms which were thought
to be primary or interfering factors causing infections in the
aetiopathogenesis of JIA and also adding speciﬁc antimi-
crobial therapy to the standard regimen of JIA therapy to
eradicate these microorganisms. The relationship between
JIA aetiopathogenesis and microorganisms has to be clariﬁed
for the above reasons. To reach this goal, we suppose that
conducting larger, serial, especially molecular based serial
studies which include samples from synovial regions which
are very difﬁcult sampling will be helpfull.
doi:10.1016/j.ijid.2008.05.167
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Background: Diarrheagenic E. coli (DEC) represents an
important group of enteric pathogens that cause human
diarrhea and has been of increasing public concerns recent
years. Since it is not easily distinguished from normal non-
pathogenic ﬂora due to inappropriate diagnostic methods,
modern molecular diagnostic assays are required. Several
distinct groups of E. coli which include the enteropathogenic
(EPEC), enteroinvasive (EIEC), enteroaggregative (EAEC),
enterotoxigenic (ETEC) and Shiga toxin-producing (STEC)
strains are important causes of diarrheal diseases in devel-
oping countries. The aim of this study was to evaluate the
contribution of the different DEC categories to children’s
diarrhea.
Methods: Molecular techniques were used for studying
the epidemiology of diarrheal infections due to DEC in Iran.
In total, 750 E. coli strains isolated from stools of 200
patients with diarrhea were collected between JUN and SEP
2007. Polymerase chain reaction (PCR) was performed to
determine the presence of the genes encoding DEC viru-
lence factors including: eaeA, bfpA, estA, eltB, inv, stx and
pCVD432, as virulence markers to distinguish EPEC, ETEC,
EIEC, STEC and EAEC.
Results: ETEC strains were isolated from 13 children
(6.5%). The distribution of these strains according to the
type of enterotoxin synthesized was as follows: 10 strains
(76.9%) produced the heat-stable toxin (ST), 2 strains
(15.4%) synthesized the heat-labile toxin (LT), and 1 strain
(7.7%) produced both toxins. EAEC strains were isolated from
16 (8%) children, and STEC was detected in 7 children (3.5%);
no EIEC strains were isolated. two of these 16 EAEC strains
also produced ST toxin. Finally, EPEC strains were isolated in
41 cases (20.5%). In this study, two PCR techniques, ampli-
fying the bfpA gene, or the eaeA gene, were used to detect
EPEC strains. Forty-one strains were found to have at least
one of these genes; 29 of the 41 strains had only the eaeA
gene, 3 strains had only the bfpA gene, 9 strains were both
genes positive. Therefore, it seems that the presence of the
eaeA gene is more highly linked to EPEC than is the presence
of the bfp gene.
Conclusion: PCR was shown to be useful technique for
the epidemiological study of DEC where this organism is a
major cause of diarrhea. In this study, EPEC was found to be
the category of DEC which most frequently causes diarrhea
in children under 5 years of age, as has been reported for
many developing countries.
doi:10.1016/j.ijid.2008.05.168
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Background: In preparation for therapeutic use of tige-
cycline (ﬁrst in class glycylcycline) in Japan, a retrospective
sample of clinical isolates (2003—2004) was tested by the
SENTRY Antimicrobial Surveillance Program. All tests were
by reference methods.
Methods: Three university hospitals collected 1,033
pathogens for central laboratory processing by the CLSI pro-
cedures (fresh MH broth media) with concurrent quality
control. Tigecycline and 23 comparators were tested includ-
ing minocycline and tetracycline. Most numerous organisms
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were: staphylococci (303), enterococci (67), streptococci
(194), E. coli (141), other Enterobacteriaceae (132), H.
inﬂuenzae (73), M. catarrhalis (56) and Acinetobacter (16).
Interpretive criteria were those of the US-FDA as published
in the product package insert.
Results: Tigecycline MIC50 and susceptibility rates among
species were identical between sampled years and more
potent than either tetracycline or minocycline. The MIC90
range (mg/L)/% susceptible for ENT was 0.25—4/36—100
with lowest potency noted against Proteae. Amp-C (19—46%)
and ESBL strains (4—12%) were tigecycline-susceptible
(≤2mg/L). Only 2 (E. faecalis) Gram-positive cocci (GPC;
0.3%) were tigecycline-non-susceptible at 2mg/L. The MRSA
and MR-coagulase-negative staphylococcal rates were 67
and 84%. No vancomycin-resistant enterococci and only one
VISA strain was detected. H. inﬂuenzae (MIC90, 0.5mg/L;
40% Bˇ-lactamase-negative ampicillin-resistant) and M.
catarrhalis (MIC90, 0.25mg/L) were inhibited by tigecycline,
as were all Acinetobacters strains at ≤4mg/L (bimodal MIC
distribution). Tigecycline was not active against P. aerugi-
nosa (MIC90, 32mg/L).
Conclusions: Using US-FDA breakpoints, tigecycline-
resistant rates among Japanese isolates were nil for Enter-
obacteriaceae and only 0.3% for GPC. Tigecycline appears
to be active against current pathogens from Japan includ-
ing prevalent resistance phenotypes (extended-spectrum
ˇ-lactamases, MRSA, penicillin-resistant pneumococci).
doi:10.1016/j.ijid.2008.05.169
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Background: Mumps is a viral infection primarily affect-
ing the salivary glands. Although disease is usually mild and
self-limited, but some patients suffering from mumps admit
due to complication like meningitis, pancreatitis, orchitis,
and encephalitis. In the countries where there is no vacci-
nation for mumps the incidence is high with epidemic peaks
of every 2—5 years. The aim of this study was to describe
the demographic and clinical features of mumps in Iranian
children.
Methods: this study was conducted for cases of mumps
treated at Pediatric Department of Ali-ebn Abitaleb Hospi-
tal,in Rafsanjan, Iran in 2002.
123 patients aged 1—14 years were studied. The data
collected through standard history and physical exam-
ination of patients at the beginning and the end of
treatment, 9 patients did not agree to participate in this
study.
Results: 123 patients with mumps were studied 120 chil-
dren (97%) with affected salivary glands were detected on
the day of admission. 81 (66%) were male 66 (54%) of case
were in the age group of 5—9 years old, and 32% (40) in the
age group of 10—14 years, 14% (17) 1—4 years. CNS mani-
festation was diagnosed in 27 (22%) of cases, pancreatitis
in 12 (10%) and orchitis was observed in only one case with
mumps more than one complication was noted in 25 (20%)
of patients. Mumps related complications occurred between
the fourth and seventh day after the appearance of salivary
gland involvement (4.23± .67).
Dehydration was diagnosed in 37% of the cases at time
of admission. All the patients who hospitalized were well
going.
Conclusion: although this was an actual epidemiologic
problem in Iran up to 2002, since then mumps vaccination
program is being done for Iranian children and the epidemic
periods have not been seen that was an end to epidemic
period of mumps in Iran.
doi:10.1016/j.ijid.2008.05.170
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Background: The preliminary part of a vaccine probe
study designed to estimate the preventable burden of
Haemophilus Inﬂuenza related severe illness in young chil-
dren in India provided sufﬁcient data to estimate the
burden of disease due to meningitis and pneumonia in
this population. The study did not proceed to the probe
trial as randomization was not considered ethical following
WHO recommendation that the vaccine be introduced. We
present ﬁndings of the preliminary part of this study at the
Vellore site.
Methods: A cohort of 5107 children (4226.6 child years)
was followed up to the age of two from one administra-
tive block in Tamil Nadu between July 2005 and January
2007. Hospitalization at study hospitals was documented
by study personnel. While no active surveillance for mor-
bidity was undertaken at the community, study personnel,
during fortnightly home visits, encouraged parents to uti-
lize study hospitals for healthcare. The hospital component
of the study included all admissions during the study period
from the cohort as well as non cohort admissions to study
hospitals with severe pneumonia or meningitis in the study
age group.
Results: There were 131 episodes of hospitalized severe
clinical pneumonia in the cohort (Incidence - 31 per 1000
child-years (26—36.9)) and 2 cases of purulent meningi-
tis (Incidence - 46/100,000 child-years (5.73—170.85)). The
hospital study recruited 457 children with severe pneumo-
nia and 37 with purulent meningitis. Of those with purulent
meningitis, 12 (32.4%) tested positive for Hib, 6 (16.2%) for
Pneumococci and 2 (5.4%) for other organisms. 70 cases of
severe pneumonia (53%) from the cohort had a readable
chest radiograph. 18 (25.7%) of these had primary con-
solidation. With conservative assumptions we estimate the
incidence of severe pneumonia with radiologic endpoint to
be 5.7 per 1000 child-years
Conclusions: Extrapolating information from hospital
study to the cohort suggests that the rates of invasive Hib
disease are consistent with global estimates.
doi:10.1016/j.ijid.2008.05.171
